The option, which expires at the end of March, gives the company a foothold in the U.S. ETF market as speculation whirls around the approval of a spot bitcoin product.Finance, news, CoinShares, Valkyrie, Acquisitions, ETFsRead More

You might also be interested in reading ‘I’ll see my grandson grow up’: New NHS bladder cancer treatment doubles survival time.